CVC NewsPress Release

INNOBRAIN: optimizing the cognitive rehabilitation of neurological and psychiatric patients

<a href=''>Vector de Fondo creado por freepik</a>

The Catalan consortia INNOBRAIN explores computer-human interaction and artificial intelligence algorithms to predict intervention results. The initiative is part of NEXTHEALTH, the RIS3CAT community participated by CVC which is aimed to innovation in Health coordinated by Biocat and supported by ACCIÓ.

A new technological platform will facilitate the stimulation and congitive rehabilitation of people with cognitive impairment as a consequence of a neurological or psychiatric disease, dementia or development disorders. This project, in which CVC is actively working with the participacion of Dr. Sergio Escalera, forms part of NextHealth, a RIS3CAT community lead by Biocat, supported by ACCIÓ and the European Union, through the European Regional Development Fund.

The INNOBRAIN consortia Works to integrate new technologies in the cognitive rehabilitation and stimulation of neurological and psychiatric patients, as is human-computer interaction, tracking emotional expressions with artificial vision, or artificial intelligence algorithms to predict the end result of interventions and improve treatment personalization, among other innovative elements.

Dr. Sergio Escalera, Principal Researcher within this project at CVC, will be implementing computer vision technology in order to recognise emotional expressions of both children and adults which have suffered from neurological disorders or disease. In this way, clinicians will be able to monitor neurorehabilitation and its evolution, in some cases with the use of videogames, by measuring level of attention, distraction, frustration and engagement.

The aim of the consortia is to boost strategic industrial research activities in order to improve usability, efficiency, effectiveness, the generation of knowledge and the personalization of treatments, as added value elements in cognitive rehabilitation and stimulation”, as explained by the Research coordinator at Guttmann, Dr. Josep M. Tormos.

The INNOBRAIN consortia is integrated by the Guttmann Institute, EURECAT, the Institut d’Investigació en Intel·ligència Artificial (IIIA-CSIC), the Computer Vision Center, the Sanitary Corporation Parc Taulí from Sabadell, the Institut d’Investigació Biomèdica de Girona (IdibGI), the Institut d’Assistència Sanitària (IAS), the Fundació Salut i Envelliment UAB ; the Institut ‘Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); and the businesses Starlab, specialist in neuroestimulation; SKY&EARTH, specialist in digital interactive vídeos, and ICA, a Technology services provider.

More information at the project’s website:


alexandra canet

The author alexandra canet